Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Massive study to track Real-Life results for advanced prostate cancer treatment

NCT ID NCT07344779

Not yet recruiting Knowledge-focused Sponsor: Bayer Source: ClinicalTrials.gov ↗

Summary

This study aims to understand how well a drug combination works for advanced prostate cancer in real-world settings, outside of controlled clinical trials. It will observe about 1,600 men in Europe who are already starting this treatment as part of their regular care. The main goal is to see how many men achieve very low levels of a key prostate cancer marker (PSA) after one year of treatment.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTATIC HORMONE-SENSITIVE PROSTATE CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Many Locations

    Multiple Locations, Belgium

  • Many Locations

    Multiple Locations, Finland

  • Many Locations

    Multiple Locations, France

  • Many Locations

    Multiple Locations, Germany

  • Many Locations

    Multiple Locations, Greece

  • Many Locations

    Multiple Locations, Israel

  • Many Locations

    Multiple Locations, Italy

  • Many Locations

    Multiple Locations, Lithuania

  • Many Locations

    Multiple Locations, Norway

  • Many Locations

    Multiple Locations, Poland

  • Many Locations

    Multiple Locations, Portugal

  • Many Locations

    Multiple Locations, Saudi Arabia

  • Many Locations

    Multiple Locations, Spain

  • Many Locations

    Multiple Locations, Sweden

  • Many Locations

    Multiple Locations, Switzerland

  • Many Locations

    Multiple Locations, United Kingdom

Conditions

Explore the condition pages connected to this study.